CRISPR Therapeutics AG (25) | Uncategorized (9)

Recent Contracts

Description of Capital Shares (Filed With SEC on February 15, 2022)
Letter Agreement dated December 16, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc (Filed With SEC on February 15, 2022)
Letter Agreement dated January 6, 2022, by and between CRISPR Therapeutics, Inc. and 105 W First Street Owner, L.L.C (Filed With SEC on February 15, 2022)
Letter Agreement dated April 29, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc (Filed With SEC on July 29, 2021)
Description of Capital Shares (Filed With SEC on February 16, 2021)
Lease, dated July 24, 2020, by and between the Registrant and 105 W First Street Owner, L.L.C (Filed With SEC on July 27, 2020)
Description of Capital Shares (Filed With SEC on February 12, 2020)
Option Agreement, dated December 13, 2019, between CRISPR Therapeutics AG and Bayer HealthCare LLC (Filed With SEC on February 12, 2020)
Open Market Sale AgreementSM, dated August 30, 2019, by and between CRISPR Therapeutics AG and Jefferies LLC (Filed With SEC on August 30, 2019)